Long-term biochemical progression-free survival following brachytherapy for prostate cancer: Further insight into the role of short-term androgen deprivation and intermediate risk group subclassification

INTRODUCTION: Brachytherapy is a well-established treatment of localized prostate cancer. Few studies have documented long-term results, specifically biochemical progression-free survival (bPFS) in men with brachytherapy alone, with or without short-term androgen deprivation therapy (ADT), or in com...

Descripción completa

Detalles Bibliográficos
Autores principales: Matzkin, Haim, Chen, Juza, Agai, Rubi, Ziv-Baran, Tomer, Mabjeesh, Nicola J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474628/
https://www.ncbi.nlm.nih.gov/pubmed/31002732
http://dx.doi.org/10.1371/journal.pone.0215582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474628/
https://www.ncbi.nlm.nih.gov/pubmed/31002732
http://dx.doi.org/10.1371/journal.pone.0215582

Ejemplares similares